3‐Ketosteroid 9α‐hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis

Mycobacterium tuberculosis H37Rv contains the kshA (Rv3526) and kshB (Rv3571) genes, encoding 3‐ketosteroid 9α‐hydroxylase (KSH). Consistent with their predicted roles, the ΔkshA and ΔkshB deletion mutants of M. tuberculosis H37Rv were unable to use cholesterol and 4‐androstene‐3,17‐dione as primary carbon and energy sources. Interestingly, ΔkshA and ΔkshB mutants were also unable to metabolize the steroid substrate 5α‐androstane‐3,17‐dione, whereas wild‐type M. tuberculosis H37Rv could. The deletion of either of these genes lead to rapid death of the microorganism in murine infection models and in macrophages, showing that kshA and kshB are essential factors for M. tuberculosis pathogenesis. Penta‐acylated trehalose (PAT) biosynthesis was altered in the ΔkshB mutant, but not the ΔkshA mutant. The ΔkshB mutant synthesizes all other types of lipids. The ΔkshB mutant had a thickened outer layer in its cell wall. KshB thus appears to be involved in multiple processes, probably as a reductase of different oxygenases. We conclude that an impaired 3‐ketosteroid 9α‐hydroxylase activity is the cause of the highly attenuated phenotype of our M. tuberculosis H37Rv mutants.

[1]  L. Dijkhuizen,et al.  Rhodococcus rhodochrous DSM 43269 3-Ketosteroid 9α-Hydroxylase, a Two-Component Iron-Sulfur-Containing Monooxygenase with Subtle Steroid Substrate Specificity , 2009, Applied and Environmental Microbiology.

[2]  Christopher M. Sassetti,et al.  igr Genes and Mycobacterium tuberculosis Cholesterol Metabolism , 2009, Journal of bacteriology.

[3]  N. Strynadka,et al.  Characterization of 3-Ketosteroid 9α-Hydroxylase, a Rieske Oxygenase in the Cholesterol Degradation Pathway of Mycobacterium tuberculosis* , 2009, Journal of Biological Chemistry.

[4]  W. Jacobs,et al.  Studies of a Ring-Cleaving Dioxygenase Illuminate the Role of Cholesterol Metabolism in the Pathogenesis of Mycobacterium tuberculosis , 2009, PLoS pathogens.

[5]  R. Loria.  Beta-Androstenes and Resistance to Viral and Bacterial Infections , 2009, Neuroimmunomodulation.

[6]  L. Dijkhuizen,et al.  The Actinobacterial mce4 Locus Encodes a Steroid Transporter* , 2008, Journal of Biological Chemistry.

[7]  L. Dijkhuizen,et al.  A novel method to generate unmarked gene deletions in the intracellular pathogen Rhodococcus equi using 5-fluorocytosine conditional lethality , 2008, Nucleic acids research.

[8]  Christopher M. Sassetti,et al.  Mycobacterial persistence requires the utilization of host cholesterol , 2008, Proceedings of the National Academy of Sciences.

[9]  S. Cole,et al.  A Point Mutation in the Two-Component Regulator PhoP-PhoR Accounts for the Absence of Polyketide-Derived Acyltrehaloses but Not That of Phthiocerol Dimycocerosates in Mycobacterium tuberculosis H37Ra , 2007, Journal of bacteriology.

[10]  I. Smith,et al.  Rv1106c from Mycobacterium tuberculosis is a 3β-hydroxysteroid dehydrogenase , 2007 .

[11]  Ben Sidders,et al.  A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis , 2007, Molecular microbiology.

[12]  Christopher J Petzold,et al.  Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling , 2007, Proceedings of the National Academy of Sciences.

[13]  L. Dijkhuizen,et al.  A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages , 2007, Proceedings of the National Academy of Sciences.

[14]  Sébastien Rodrigue,et al.  Posttranslational Regulation of Mycobacterium tuberculosis Extracytoplasmic-Function Sigma Factor σL and Roles in Virulence and in Global Regulation of Gene Expression , 2006, Infection and Immunity.

[15]  F. Movahedzadeh,et al.  Deletion of the Mycobacterium tuberculosis α-Crystallin-Like hspX Gene Causes Increased Bacterial Growth In Vivo , 2006, Infection and Immunity.

[16]  E. Rubin,et al.  Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Pavelka,et al.  Identification of the namH Gene, Encoding the Hydroxylase Responsible for the N-Glycolylation of the Mycobacterial Peptidoglycan* , 2005, Journal of Biological Chemistry.

[18]  D. Kaul,et al.  Cholesterol-sensor initiates M. tuberculosis entry into human macrophages , 2004, Molecular and Cellular Biochemistry.

[19]  Christopher M. Sassetti,et al.  Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  I. Orme,et al.  Sulfolipid Deficiency Does Not Affect the Virulence of Mycobacterium tuberculosis H37Rv in Mice and Guinea Pigs , 2003, Infection and Immunity.

[21]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[22]  L. Dijkhuizen,et al.  Molecular and functional characterization of the kstD2 gene of Rhodococcus erythropolis SQ1 encoding a second 3-ketosteroid Delta(1)-dehydrogenase isoenzyme. , 2002, Microbiology.

[23]  V. Dubey,et al.  Disruption of msl3 abolishes the synthesis of mycolipanoic and mycolipenic acids required for polyacyltrehalose synthesis in Mycobacterium tuberculosis H37Rv and causes cell aggregation , 2002, Molecular microbiology.

[24]  L. Dijkhuizen,et al.  Molecular and functional characterization of kshA and kshB, encoding two components of 3‐ketosteroid 9α‐hydroxylase, a class IA monooxygenase, in Rhodococcus erythropolis strain SQ1 , 2002, Molecular microbiology.

[25]  Gurdyal S Besra,et al.  The methyl-branched fortifications of Mycobacterium tuberculosis. , 2002, Chemistry & biology.

[26]  G. Bancroft,et al.  Characterization of Auxotrophic Mutants ofMycobacterium tuberculosis and Their Potential as Vaccine Candidates , 2001, Infection and Immunity.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  T. Parish,et al.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. , 2000, Microbiology.

[29]  M. Rajandream,et al.  Regulation of hmp Gene Transcription inMycobacterium tuberculosis: Effects of Oxygen Limitation and Nitrosative and Oxidative Stress , 1999, Journal of bacteriology.

[30]  Rook,et al.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice , 1998, Immunology.

[31]  N. Fujiwara.  [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence]. , 1997, Kekkaku : [Tuberculosis].

[32]  P. Gounon,et al.  Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species , 1996, Journal of bacteriology.

[33]  P. Gounon,et al.  Molecular composition of the outermost capsular material of the tubercle bacillus. , 1995, Microbiology.

[34]  G. Besra,et al.  Characterization of the specific antigenicity of Mycobacterium fortuitum. , 1992, Biochemistry.

[35]  W. Jacobs,et al.  Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Orme.  A mouse model of the recrudescence of latent tuberculosis in the elderly. , 1988, The American review of respiratory disease.

[37]  K. Kanai,et al.  Accumulation of cholesterol esters in macrophages incubated with mycobacteria in vitro. , 1976, Japanese journal of medical science & biology.

[38]  T. Parish,et al.  Electroporation of mycobacteria. , 2009, Methods in molecular biology.

[39]  G. Besra.  Preparation of cell-wall fractions from mycobacteria. , 1998, Methods in molecular biology.

[40]  A. Kochi,et al.  Tuberculosis: a global overview of the situation today. , 1992, Bulletin of the World Health Organization.